Dmitry Balyasny’s Pediatrix Medical MD Stock Holding History

Dmitry Balyasny’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-146,400	Closed	-$9.76M	–	1709
2016 Q4	$9.76M	Buy	+146,400	New	+$9.52M	0.05%	481

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dmitry Balyasny's MD Position: Q2 2026 in Review

Dmitry Balyasny sold out of Pediatrix Medical (MD) in Q2 2026, closing a stake of 10,860 shares — an estimated $232K sold.

Dmitry Balyasny first reported a position in MD in Q3 2015 and held it in 14 quarters. The position peaked at $64M in Q2 2017. 302 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Dmitry Balyasny reported no remaining Pediatrix Medical position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 10,860 Pediatrix Medical shares in Q2 2026, an estimated $232K.
Dmitry Balyasny first reported a position in Pediatrix Medical in Q3 2015 and held it in 14 quarters.
Dmitry Balyasny's Pediatrix Medical position peaked at $64M in Q2 2017.
302 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.